BIO-key International, Inc.
BKYI
$0.71
-$0.03-3.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.55% | 29.97% | -44.33% | 41.65% | 59.79% |
| Total Depreciation and Amortization | -22.71% | 0.30% | -3.73% | 0.92% | 48.96% |
| Total Amortization of Deferred Charges | -13.29% | 9.18% | 20.16% | 278.10% | 7.95% |
| Total Other Non-Cash Items | 300.18% | 432.09% | 4.34% | -115.10% | -104.56% |
| Change in Net Operating Assets | 38.40% | -87.61% | -184.85% | 245.51% | -283.06% |
| Cash from Operations | 12.01% | 38.05% | -381.15% | 66.40% | -665.45% |
| Capital Expenditure | 93.87% | -- | -142.11% | 1,100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.87% | -- | -142.11% | 1,100.00% | -- |
| Total Debt Issued | 1,188.14% | -- | -- | -- | -- |
| Total Debt Repaid | -54.32% | -2.81% | 16.27% | 63.23% | 57.81% |
| Issuance of Common Stock | -100.00% | -52.63% | 272,264.29% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -1,742.96% | 96.01% | -429.13% |
| Cash from Financing | -44.94% | -101.82% | 6,647.68% | -153.48% | 2,203.49% |
| Foreign Exchange rate Adjustments | -182.20% | 142.98% | 110.91% | -114.27% | 1,145.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.55% | -250.62% | 1,406.20% | -767.40% | 309.29% |